HLS Therapeutics Inc. (TSX:HLS)
Canada · Delayed Price · Currency is CAD 5.22
-0.04 (-0.76%)
Aug 22, 2025, 3:59 PM EDT
HLS Therapeutics Employees
HLS Therapeutics had 92 employees as of December 31, 2024. The number of employees increased by 1 or 1.10% compared to the previous year.
Employees
92
Change (1Y)
1
Growth (1Y)
1.10%
Revenue / Employee
836.42K CAD
Profits / Employee
-223.02K CAD
Market Cap
163.88M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 92 | 1 | 1.10% |
| Dec 31, 2023 | 91 | -8 | -8.08% |
| Dec 31, 2022 | 99 | 7 | 7.61% |
| Dec 31, 2021 | 92 | 4 | 4.55% |
| Dec 31, 2020 | 88 | 24 | 37.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Curaleaf Holdings | 5,519 |
| Green Thumb Industries | 4,800 |
| Trulieve Cannabis | 6,000 |
| Sienna Senior Living | 12,263 |
| dentalcorp Holdings | 10,200 |
| Cronos Group | 459 |
| WELL Health Technologies | 1,507 |
| Extendicare | 23,000 |
HLS Therapeutics News
- 4 days ago - HLS Therapeutics announces new credit agreement - Seeking Alpha
- 10 days ago - HLS Therapeutics Announces Q2 2025 Financial Results - Benzinga
- 7 weeks ago - HLS Therapeutics Announces Reimbursement for Vascepa® under Nova Scotia's Provincial Drug Plan - Benzinga
- 3 months ago - HLS Therapeutics reports Q1 results - Seeking Alpha
- 3 months ago - HLS Therapeutics Announces Q1 2025 Financial Results - Benzinga
- 5 months ago - HLS Therapeutics GAAP EPS of -$0.10, revenue of $15.5M misses by $0.2M - Seeking Alpha
- 5 months ago - HLS Therapeutics Announces Fiscal 2024 Financial Results and Normal Course Issuer Bid - Benzinga
- 10 months ago - HLS Therapeutics GAAP EPS of -$0.15 beats by $0.04, revenue of $14.08M misses by $6.42M - Seeking Alpha